1.14
전일 마감가:
$1.16
열려 있는:
$1.18
하루 거래량:
267.77K
Relative Volume:
0.15
시가총액:
$208.06M
수익:
$137.74M
순이익/손실:
$-27.97M
주가수익비율:
-7.125
EPS:
-0.16
순현금흐름:
$-9.61M
1주 성능:
-3.81%
1개월 성능:
-14.02%
6개월 성능:
-50.87%
1년 성능:
-36.24%
Heron Therapeutics Inc Stock (HRTX) Company Profile
명칭
Heron Therapeutics Inc
전화
(858) 251-4400
주소
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
HRTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
HRTX
Heron Therapeutics Inc
|
1.135 | 212.64M | 137.74M | -27.97M | -9.61M | -0.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.65 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
638.50 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
443.80 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.69 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.38 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-09 | 개시 | H.C. Wainwright | Buy |
| 2024-06-13 | 개시 | Rodman & Renshaw | Buy |
| 2024-04-23 | 개시 | CapitalOne | Overweight |
| 2024-03-13 | 재확인 | Needham | Buy |
| 2020-05-27 | 개시 | Guggenheim | Buy |
| 2020-02-20 | 재확인 | Needham | Buy |
| 2019-01-16 | 재확인 | Needham | Buy |
| 2018-04-05 | 개시 | Evercore ISI | Outperform |
| 2018-03-19 | 재확인 | Mizuho | Buy |
| 2018-03-01 | 재확인 | Needham | Buy |
| 2018-01-03 | 개시 | Leerink Partners | Outperform |
| 2017-09-27 | 개시 | Northland Capital | Outperform |
| 2017-02-27 | 개시 | Needham | Buy |
| 2016-10-26 | 개시 | Aegis Capital | Buy |
| 2016-09-06 | 재개 | Lake Street | Buy |
| 2016-05-03 | 개시 | Cantor Fitzgerald | Buy |
| 2015-12-10 | 개시 | Lake Street | Buy |
| 2015-09-23 | 재확인 | Leerink Partners | Outperform |
| 2015-09-02 | 개시 | BofA/Merrill | Buy |
| 2015-08-03 | 재확인 | Brean Capital | Buy |
| 2015-06-30 | 재확인 | JMP Securities | Mkt Outperform |
| 2015-06-19 | 재확인 | Leerink Partners | Outperform |
| 2014-08-07 | 개시 | Noble Financial | Buy |
모두보기
Heron Therapeutics Inc 주식(HRTX)의 최신 뉴스
Ranking Heron Therapeutics Inc. among high performing stocks via toolsJuly 2025 Price Swings & Verified Entry Point Signals - newser.com
Heron Therapeutics Inc. stock prediction for this week2025 Historical Comparison & Consistent Growth Stock Picks - newser.com
Why Heron Therapeutics Inc. (AXD2) stock could rally strongly2025 Performance Recap & Accurate Entry and Exit Point Alerts - newser.com
Can trapped investors hope for a rebound in Heron Therapeutics Inc.2025 Biggest Moves & Daily Risk Controlled Trade Plans - newser.com
Will Heron Therapeutics Inc. stock attract more institutional investorsInsider Selling & Reliable Breakout Forecasts - newser.com
Tools to monitor Heron Therapeutics Inc. recovery probabilityWeekly Gains Report & Risk Controlled Swing Alerts - newser.com
Should you wait for a breakout in Heron Therapeutics Inc.Portfolio Return Report & Entry and Exit Point Strategies - newser.com
Sentiment analysis tools applied to Heron Therapeutics Inc.2025 Price Targets & Risk Controlled Daily Plans - newser.com
Is Heron Therapeutics Inc. (AXD2) stock inflation resilient2025 Top Gainers & Reliable Volume Spike Trade Alerts - newser.com
Heron Therapeutics Inc. stock daily chart insightsWeekly Trade Analysis & Reliable Entry Point Alerts - newser.com
Can Heron Therapeutics Inc. recover in the next quarterJuly 2025 News Drivers & Fast Entry Momentum Alerts - newser.com
Heron Therapeutics Inc. stock chart pattern explainedJuly 2025 Movers & Safe Capital Growth Tips - newser.com
What MACD and RSI say about Heron Therapeutics Inc.Weekly Trade Report & Free Safe Capital Growth Stock Tips - newser.com
Developing predictive dashboards with Heron Therapeutics Inc. dataTrade Ideas & Verified Technical Signals - newser.com
Can Heron Therapeutics Inc. stock weather global recessionJuly 2025 Decliners & Verified Momentum Stock Ideas - newser.com
Detecting price anomalies in Heron Therapeutics Inc. with AI2025 Market WrapUp & Safe Entry Point Identification - newser.com
Will Heron Therapeutics Inc. stock outperform Nasdaq indexTrade Entry Report & Fast Moving Trade Plans - newser.com
Why Heron Therapeutics Inc. (AXD2) stock attracts wealthy investorsJobs Report & Growth Oriented Trading Recommendations - newser.com
Heron Therapeutics Appoints Thomas Cusack to Board - The Globe and Mail
Can Heron Therapeutics Inc. (AXD2) stock deliver consistent EPS growthQuarterly Profit Review & Detailed Earnings Play Alerts - newser.com
Published on: 2025-10-30 01:17:43 - newser.com
Heron Therapeutics, Inc. Appoints Thomas Cusack to Board of Directors - Quiver Quantitative
Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors - GlobeNewswire
Heron (NASDAQ: HRTX) names Thomas Cusack to board; ex-Starboard MD at $9B fund - Stock Titan
Heron Therapeutics (HRTX) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Heron Therapeutics Inc (HRTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Heron Therapeutics Inc 주식 (HRTX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Morgan Adam | Director |
Aug 08 '25 |
Buy |
1.50 |
1,766,546 |
2,649,819 |
8,753,290 |
자본화:
|
볼륨(24시간):